Research Grants Awarded by Shock Society

The grants aim to give early career researchers the opportunity and resources to develop their independent research. The Research Grant for Hemorrhagic Shock and Hemostatis was awarded by the Shock Society and Novo Nordisk (Copenhagen, Denmark). Winners can utilize the grants at their home institutions and are invited to participate in a ‘visiting scientist' program at Novo Nordisk's new research laboratories in North Brunswick (NJ, USA).

The European grant winner, Dr. Johanna Catharina Duvigneau, from the Veterinary University Vienna (Austria) won in recognition of her research proposal for examining the role of iron metabolism in hemorrhagic shock. A deeper understanding of iron metabolism modulation may reduce organ failures and death in trauma. Dr. Duvigneau's research will investigate to what extent iron plays a role in organ damage, and whether two enzyme systems impacting the availability and toxicity of iron can be modulated to reduce organ damage and potentially save lives. Dr. Duvigneau will receive 100,000 euros to further her research.

The U.S. winner, Dr. Stephen Trzeciak, M.D., of the Camden Cooper University Hospital (NJ, USA), won in recognition of his research proposal to examine the impact of global tissue hypoxia on the modulation of hemostasis in early resuscitation for septic shock. Early resuscitation may reduce septic shock progression and may provide insights into new therapeutic strategies targeting the hemostasis system. Dr. Trzeciak will receive 96,000 euros to further his research.

The mission of the European and U.S. shock societies is to improve the care of victims of trauma, shock, and sepsis by promoting relevant research into basic biology, providing a multidisciplinary forum to integrate and disseminate new knowledge, and promoting the education and mentoring of the next generation of investigators in the field of trauma, shock, and sepsis.



Related Links:
Novo Nordisk
The Shock Society